Morbidity associated with nonemergent hysterectomy for placenta accreta


      The purpose of this study was to report the morbidity of nonemergent hysterectomy for suspected placenta accreta.

      Study Design

      This was a retrospective study of all patients who underwent nonemergent hysterectomy for placenta accreta at Tampa General Hospital from June 1, 2003 to May 31, 2009.


      Twenty-nine patients were identified. Diagnosis was suspected on ultrasound scanning in 26 women (6 women also underwent magnetic resonance imaging) and on direct vision at repeat cesarean section delivery in 3 women. All of the women were multiparous, and 18 women had undergone ≥2 cesarean section deliveries. Twenty-one women had a placenta previa, and 8 women had a low anterior placenta. Final pathologic findings revealed accreta (20 specimens), increta (6 women), and percreta (3 women). Mean total operative time was 216 minutes; blood loss was 4061 mL. Two women had ureteral transection (1 was bilateral); 3 women had cystotomy, and 3 women had partial cystectomy. Postoperative hemorrhage occurred in 5 women; 1 hemorrhage resolved after catheter embolization, and the other 4 hemorrhage required reoperation.


      Nonemergent hysterectomy for placenta accreta is associated with significant morbidity in the forms of hemorrhage and urinary tract insult.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Eller A.
        • Porter T.
        • Soisson P.
        • Silver R.
        Optimal management strategies for placenta accreta.
        BJOG. 2009; 116: 648-654
        • Stafford I.
        • Belfort M.
        Placenta accreta, increta, and percreta: lifesaving strategies to stop the bleeding.
        Contemp OB/GYN. 2008; : 48-53
        • Resnik R.
        Managing placenta accreta.
        Contemp OB/GYN. 2001; : 122-126
        • American College of Obstetricians and Gynecologists
        Placenta accreta: ACOG committee opinion no. 266.
        Obstet Gynecol. 2002; 99: 169-170
        • Wu S.
        • Kocherginsky M.
        • Hibbard J.
        Abnormal placentation: twenty-year analysis.
        Am J Obstet Gynecol. 2005; 192: 1458-1461
        • Dubois J.
        • Garel L.
        • Grignon A.
        • Lemay M.
        • Leduc L.
        Placenta percreta: balloon occlusion and embolization of the internal iliac arteries to reduce intraoperative blood losses.
        Am J Obstet Gynecol. 1997; 176: 723-726
        • Kidney D.
        • Nguyen A.
        • Ahdoot D.
        • Bickmore D.
        • Deutsch L.
        • Majors C.
        Prophylactic perioperative hypogastric artery balloon occlusion in abnormal placentation.
        AJR Am J Roentgenol. 2001; 176: 1521-1524
        • Bodner L.
        • Nosher J.
        • Gribbin C.
        • Siegel R.
        • Beale S.
        • Scorza W.
        Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta.
        Cardiovasc Intervent Radiol. 2006; 29: 354-361
        • Shrivastava V.
        • Nageotte M.
        • Major C.
        • Haydon M.
        • Wing D.
        Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta.
        Am J Obstet Gynecol. 2007; 197 (402.e1-5)
      1. Mangar D, Kolla J, Karlnoski R, Omar H, Hoffman M, Camporesi E. Selective endovascular balloon-occlusion for cesarean delivery in patients with abnormal placentation: review of literature and presentation of a case. J Gynecol Surg [In Press].

        • Jaffe R.
        • DuBeshter B.
        • Sherer D.
        • Thompson E.
        • Woods J.
        Failure of methotrexate treatment for term placenta percreta.
        Am J Obstet Gynecol. 1994; 171: 558-559
        • Legro R.
        • Price F.
        • Hill L.
        • Caritis S.
        Nonsurgical management of placenta percreta: a case report.
        Obstet Gynecol. 1994; 83: 847-849
        • Butt K.
        • Gagnon A.
        • Delisle M.-F.
        Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta.
        Obstet Gynecol. 2002; 99: 981-982
        • Armstrong A.
        • Harding S.
        • Dickinson J.
        Clinical aspects and conservative management of placenta accreta.
        Obstet Gynecol. 2004; 6: 132-137
        • Kayem G.
        • Davy C.
        • Goffinet F.
        • Thomas C.
        • Clement D.
        • Cabrol D.
        Conservative versus extirpative management in cases of placenta accreta.
        Obstet Gynecol. 2004; 104: 531-536
        • Sameshima H.
        • Doi K.
        • Ikenoue T.
        Selective manual removal of invasive placentation at cesarean section: 13 consecutive cases in a regional tertiary center.
        J Gynecol Surg. 2008; 24: 101-104
        • Hays A.
        • Worley K.
        • Roberts S.
        Conservative management of placenta percreta: experiences in two cases.
        Obstet Gynecol. 2008; 112: 425-426
        • Shellhaas C.
        • Gilbert S.
        • Landon M.
        • et al.
        The frequency and complication rates of hysterectomy accompanying cesarean delivery.
        Obstet Gynecol. 2009; 114: 224-229
        • Pelosi III, M.A.
        • Pelosi M.A.
        Modified cesarean hysterectomy for placenta previa percreta with bladder invasion: retrovesical lower uterine segment bypass.
        Obstet Gynecol. 1999; 93: 830-833
        • Chou M.
        • Hwang J.
        • Tseng J.
        • Ho E.
        Internal iliac artery embolization before hysterectomy for placenta accreta.
        J Vasc Interv Radiol. 2003; 14: 1195-1199
        • Lee P.
        • Bakelaar R.
        • Fitzpatrick C.
        • Ellestad S.
        • Havrilesky L.
        • Alvarez-Accord A.
        Medical and surgical treatment of placenta percreta to optimize bladder preservation.
        Obstet Gynecol. 2008; 112: 421-424
        • O'Connell K.
        • Wood J.
        • Wise R.
        Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.
        JAMA. 2006; 295: 293-298